Technology areas: Biotechnology & Pharmaceuticals • Chemistry & Materials
3 pending office actions • 2 art units • 3 examiners • 0 of 3 (0%) have an AI response strategy ready • 2 patents granted in the last 365 days
Randox Laboratories Ltd. has 3 pending office actions in Chemistry & Materials. The matters involve 3 distinct examiners and 2 distinct art units, indicating that examiner assignments are more varied than the art-unit assignments.
NGUYEN, HENRY H is the busiest examiner, with 1 pending action. Counsel should maintain separate examiner-based response planning while comparing matters assigned to the same art unit for potentially consistent prosecution issues.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 1 (33%) |
| Multi-statute (no §101) | 2 (67%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| NGUYEN, HENRY H | 1 | 63.5% | +36.7% |
| KWAK, DEAN P | 1 | 58.8% | +37.1% |
| LUSI, ELLIS FOLLETT | 1 | 64.0% | +53.7% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 3 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18696817 | DETECTION OF BLADDER CANCER IN MALES | NGUYEN, HENRY H | — |
| 18576835 | Sample Extractor | KWAK, DEAN P | — |
| 18037968 | METHODS FOR USE IN PREVENTATIVE HEALTHCARE | LUSI, ELLIS FOLLETT | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 3 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18696817 | DETECTION OF BLADDER CANCER IN MALES | NGUYEN, HENRY H | — |
| 18576835 | Sample Extractor | KWAK, DEAN P | — |
| 18037968 | METHODS FOR USE IN PREVENTATIVE HEALTHCARE | LUSI, ELLIS FOLLETT | — |
| Art Unit | Apps |
|---|---|
| 1758 | 1 |
| 1677 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18696817 | DETECTION OF BLADDER CANCER IN MALES | NGUYEN, HENRY H | 1758 | §102§103 | Non-Final OA | — | Pending | Mar 28, 2024 |
| 18576835 | Sample Extractor | KWAK, DEAN P | — | §102§103§112 | Non-Final OA | — | Pending | Jan 05, 2024 |
| 18037968 | METHODS FOR USE IN PREVENTATIVE HEALTHCARE | LUSI, ELLIS FOLLETT | 1677 | §101§112 | Final Rejection | — | Pending | May 19, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialRandox Laboratories Ltd. has 3 pending office actions as of October 2026, spread across 2 art units and 3 examiners.
Henry H Nguyen has the most, with 1 of Randox Laboratories Ltd.'s pending office actions.
Mostly Chemistry & Materials (USPTO Tech Center 1700), based on where its pending office actions are examined.
